Incentive Spirometry and Upper Abdominal Laparoscopic Surgery

Sponsor
Riphah International University (Other)
Overall Status
Completed
CT.gov ID
NCT04716166
Collaborator
(none)
60
1
2
7.9
7.6

Study Details

Study Description

Brief Summary

To compare the effects of volume-oriented versus flow-oriented incentive spirometry on pulmonary function tests and functional capacity in patients of upper abdominal laparoscopic surgery. Previous studies were designed to target only spirometer without focusing on its different types and their effects. This study covers the research gap and therefore is designed to observe effects of different types of spirometer on pulmonary function of patients undergoing upper abdominal laparoscopic surgery.

Condition or Disease Intervention/Treatment Phase
  • Other: Volume-oriented incentive spirometry
  • Other: Flow-oriented incentive spirometry
N/A

Detailed Description

The volume oriented incentive spirometer enables the patient to inhale air through a mouthpiece and corrugated tubing which is attached to a plastic bellows. The volume of air displaced is indicated on a scale located on the device enclosure. After the patient has achieved the maximum volume, the individual is instructed to hold this volume constant for 3 to 5 seconds.

Studies suggest a physiologically significant difference in the effect of the flow- and volume-oriented incentive spirometer. Flow-oriented devices enforce more work of breathing and increase muscular activity of the upper chest. Volume-oriented devices enforce less work of breathing and improve diaphragmatic activity.

Research was carried out a study on two experimental groups of patients in order to evaluate the effects of aerobic exercise training and incentive spirometry in controlling pulmonary complications following laparoscopic cholecystectomy, results indicated a significant reduction in heart rate, Oxygen Saturation of hemoglobin (SaO2), and inspiratory capacity for both groups. The researchers concluded that aerobic exercise and incentive spirometry were beneficial in reducing the postoperative pulmonary complications after laparoscopic cholecystectomy.

Another study observed the comparative study on the effect of preoperative and postoperative incentive spirometry on the pulmonary function of fifty patients who had undergone laparoscopic cholecystectomy. The authors concluded that pulmonary function is well-preserved with preoperative than postoperative incentive spirometry.

Another study observed that the volume incentive spirometry resulted in early recovery of both pulmonary function and diaphragm movement in patients who undergone laparoscopic abdominal surgery.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Compare the Effects of Volume-oriented Versus Flow-oriented Incentive Spirometry on Pulmonary Function and Functional Capacity in Patients of Upper Abdominal Laparoscopic Surgery
Actual Study Start Date :
Oct 1, 2020
Actual Primary Completion Date :
May 30, 2021
Actual Study Completion Date :
May 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Volume-oriented incentive spirometry

Postoperative Volume oriented incentive spirometry 3 times a day

Other: Volume-oriented incentive spirometry
3 sets of 5 repeated deep breaths using volume oriented incentive spirometry 3 times a day for 2 days

Experimental: Flow-oriented incentive spirometry

Postoperative Flow oriented incentive spirometry 3 times a day

Other: Flow-oriented incentive spirometry
3 sets of 5 repeated deep breaths using flow oriented incentive spirometry 3 times a day for 2 days

Outcome Measures

Primary Outcome Measures

  1. Functional Capacity [2 days]

    The six-minute walk test (6MWT) is a submaximal exercise test for evaluating physical functional capacity. Six meter walk distance ranges from 400 to 700 meter in normal individuals

  2. Total Lung Capacity [2 days]

    Changes from the baseline will be measured on daily basis. Pulmonary function test will be measured by using a digital spirometer. Spirometry assesses the integrated mechanical function of the lung, chest wall, respiratory muscles, and airways by measuring the total volume of air exhaled from a full lung total lung capacity [TLC] TLC has a normal value ranges from 80% to 120%, of the predicted ratio.

  3. Forced vital capacity (FVC) [2 days]

    Changes from the baseline will be measured on daily basis. Pulmonary function test will be measured by using a digital spirometer. FVC is the total volume of air that can be exhaled during a maximally forced expiration effort. It ranges from 80% to 120% of the predicted value.

  4. Forced expiratory volume in 1 second (FEV1) [2 days]

    FEV1 is the volume of air that can forcibly be blown out in the first 1 second, after full inspiration. Average values for FEV1 in healthy people depend mainly on sex and age. Values of between 80% and 120% of the average value are considered normal.

  5. FEV1/FVC ratio [2 days]

    FEEV1/FVC is the ratio of FEV1 to FVC. In healthy adults, this should be approximately 70-80%

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient with upper abdominal surgery (laparoscopy)
Exclusion Criteria:
  • Patients who had undergone open abdominal surgery and laparoscopic obstetrics and gynecological surgery.

  • Patients with unstable hemodynamic parameters (arterial pressure<100 mmHg systolic and <60 mmHg for diastolic and mean arterial Pressure (MAP) <80mmHg.

  • Patients with postoperative complications requiring mechanical ventilation.

  • Uncooperative patients or patients unable to understand or to use the device properly

  • Recent history of lower extremity fracture

Contacts and Locations

Locations

Site City State Country Postal Code
1 Railway General hospital Rawalpindi Punjab Pakistan 46000

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: Abeer Fatima, MSPT-CPPT, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Riphah International University
ClinicalTrials.gov Identifier:
NCT04716166
Other Study ID Numbers:
  • Muhammad Shakir Khan
First Posted:
Jan 20, 2021
Last Update Posted:
Oct 20, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Riphah International University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 20, 2021